High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.
Yamada Y, Fujii H, Ohata K, Kato-Hayashi H, Watanabe D, Ishihara T, Uemura S, Iwashita T, Imai H, Matsuhashi N, Takahashi T, Sugiyama T, Shimizu M, Yoshida K, Suzuki A.
Yamada Y, et al. Among authors: suzuki a.
Med Oncol. 2019 Jun 3;36(7):63. doi: 10.1007/s12032-019-1288-7.
Med Oncol. 2019.
PMID: 31161433